申请人:BRISTOL MYERS SQUIBB CO
公开号:WO2012151195A1
公开(公告)日:2012-11-08
Hepatitis C virus inhibitors having the following general formula (I); are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.